Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00639457 · ClinicalTrials.gov registry record · NA

Exercise and Pioglitazone for HIV-Metabolic Syndromes

A NA study of Obesity and HIV Infections, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT00639457 is a NA study of Obesity and HIV Infections that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 44 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00639457, a NA study of Obesity and HIV Infections, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose is to examine the safety and efficacy of 16wks of pioglitazone (Actos; 30mg/d) with and without aerobic and strength exercise training for reducing glucose intolerance and central adiposity in HIV-infected people. We anticipate that pioglitazone + exercise training will improve glucose metabolism and insulin sensitivity, and reduce central adiposity more than pioglitazone alone. These improvements should translate into reduced cardiovascular disease risk in HIV-infected people.

Interventions

  • DRUG Pioglitazone
  • BEHAVIORAL Exercise training

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2005-01
Est. Completion 2009-12
Phase NA

What the Registry Record Tells You About NCT00639457

The ClinicalTrials.gov registry entry for NCT00639457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Pioglitazone is the first listed.

NCT00639457 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00639457 about?

NCT00639457 is a clinical study titled "Exercise and Pioglitazone for HIV-Metabolic Syndromes". The purpose is to examine the safety and efficacy of 16wks of pioglitazone (Actos; 30mg/d) with and without aerobic and strength exercise training for reducing glucose intolerance and central adiposity in HIV-infected people. We anticipate that pioglitazone + exercise training will improve glucose m...

What is the current status of trial NCT00639457?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2005-01. Estimated completion is 2009-12.

What conditions does trial NCT00639457 study?

This clinical trial studies the following conditions: Obesity, HIV Infections, HIV, Type 2 Diabetes, Cardiovascular Disease.

What interventions are being tested in trial NCT00639457?

The interventions under investigation include: Pioglitazone (DRUG), Exercise training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00639457?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00639457 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.